MTI Signs Exclusive Licensing and Distribution Agreement with US Based Atlantic Diagnostic Laboratories LLC
![](/public/uploads/images/adlemail_logo/1578696158-330w_adlemail_logo.jpg)
MTI has signed a multi-million dollar exclusive licensing and distribution agreement with Atlantic Diagnostic Laboratories, LLC (ADL) for its flagship product, PolypDx™, a urine-based diagnostic test for detection of adenomatous polyps, the precursor to colorectal cancer.